TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 45,000,000 | $474,089,000 | 9.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $4,280,000 | 0.96% |
| DeepCurrents Investment Group LLC | 22,150,000 | $23,650,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,000,000 | $19,967,000 | 0.46% |
| Context Capital Management, LLC | 5,750 | $6,138,000 | 0.40% |
| WOLVERINE ASSET MANAGEMENT LLC | 34,000,000 | $36,271,000 | 0.35% |
| Polar Asset Management Partners Inc. | 15,000,000 | $15,993,000 | 0.17% |
| LINDEN ADVISORS LP | 20,000,000 | $21,281,000 | 0.13% |
| Wellesley Asset Management | 1,599 | $1,599,000 | 0.11% |
| Verition Fund Management LLC | 6,213,000 | $6,614,000 | 0.08% |